Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank33
3Y CAGR-43.2%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-43.2%/yr
vs -17.1%/yr prior
Acceleration
-26.0pp
Decelerating
Percentile
P33
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$1.64M+114.5%
2024$-11.31M-199.5%
2023$11.37M+27.6%
2022$8.91M-89.1%
2021$81.51M+190.1%
2020$-90.45M-386.7%
2019$-18.59M-198.3%
2018$18.91M+707.2%
2013$2.34M+37.0%
2012$1.71M-